Treatment for Dengue Fever
The treatment for dengue fever is primarily supportive care with careful fluid management, as there is no specific antiviral therapy available. 1
Clinical Assessment and Diagnosis
- Dengue presents with fever, headache, myalgia, rash, and leukopenia
- Diagnosis is confirmed through:
- PCR testing (acute phase)
- IgM capture ELISA
- Convalescent IgG at 3 weeks 1
- Distinguish from other febrile illnesses by:
- More severe thrombocytopenia
- Elevated liver transaminases
- Positive dengue-specific serological tests 1
Treatment Approach
Fluid Management (Critical Component)
- Initial resuscitation for patients with shock:
- Crystalloid fluid bolus of 20 ml/kg administered rapidly
- May need to be repeated 2-3 times in profound shock 1
- Maintenance fluid therapy:
- Rate: 5-10 ml/kg/hour, adjusted based on clinical response
- Normal saline is preferred over lactated Ringer's solution
- Monitor for fluid overload (dyspnea, enlarging liver, gallop rhythm, pulmonary edema) 1
Special Considerations
- Patients with chronic kidney disease: Administer lower fluid volumes
- Electrolyte management: Add 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO4) to maintenance fluids once renal function is assured 1
- Children: More susceptible to fluid overload; require closer monitoring 1
- Pregnant women: Higher risk of complications; require more intensive surveillance 1
- Older adults: Higher risk of severe dengue; may need more aggressive management 1
Monitoring Parameters
- Vital signs every 15-30 minutes during rapid fluid administration
- Monitor for warning signs of severe dengue:
- Abdominal pain or tenderness
- Persistent vomiting
- Clinical fluid accumulation
- Mucosal bleeding
- Lethargy or restlessness
- Liver enlargement
- Increasing hematocrit with rapid decrease in platelet count 1
Discharge Criteria
Patients can be discharged when they have:
- No fever for 48 hours without antipyretics
- Improving clinical status
- Increasing platelet count
- Stable hematocrit
- No respiratory distress
- Good urine output 1
Important Caveats
No specific antiviral therapy: Unlike many other viral infections, dengue has no approved specific antiviral treatment 2, 3
Avoid NSAIDs and aspirin: These medications may increase bleeding risk and should be avoided; acetaminophen is preferred for fever and pain management
Critical phase monitoring: The period of defervescence (when fever subsides, typically days 3-7) is when plasma leakage and hemorrhagic complications are most likely to occur and requires vigilant monitoring 3, 4
Prevent secondary infection: Dengue patients should be protected from mosquito bites to prevent transmission to others
Follow-up evaluation: Recommended 2-4 weeks after treatment to assess recovery 1